Tumor
Conditions
Interventions
Index test:68Ga-labeled peptides
Sponsors
The First Affiliated Hospital of Jinan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: a. The subjects voluntarily sign the informed consent form and are capable of completing the trial as per the protocol requirements. b. Age 18 years or above, both male and female are eligible. c. Patients diagnosed with solid tumor diseases such as urothelial carcinoma, breast cancer, non-small cell lung cancer, etc., through histopathology or cytology. d. Patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology reports).
Exclusion criteria
Exclusion criteria: a. Pregnant or lactating women; b. Patients with severe liver, kidney or heart dysfunction; c. Severely obese patients or those who cannot or are unable to undergo PET/CT scans; d. Patients with positive results in any one of the four infectious disease tests (hepatitis B surface antigen, hepatitis C antibody, Treponema pallidum, or HIV antibody); e. Other subjects deemed unsuitable for inclusion by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy;Sensitivity; | — |
Secondary
| Measure | Time frame |
|---|---|
| SUV;Specificity; | — |
Countries
China
Contacts
Public ContactLu Wang
Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University
Outcome results
None listed